Credit Suisse’s iHuman IH Stock Holding History

Credit Suisse’s Portfolio IH Stock Details IH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,597	Closed	-$54K	–	4584
2021 Q3	$54K	Sell	11,597 -935,203	-99%	-$6.96M	﹤0.01%	4345
2021 Q2	$9.85M	Buy	946,800 +119,188	+14%	+$1.31M	0.01%	1576
2021 Q1	$10.4M	Buy	827,612 +127,612	+18%	+$2.25M	0.01%	1570
2020 Q4	$12.7M	Buy	+700,000	New	+$15.6M	0.01%	1434

Other funds holding IH

APA

Arisaig Partners (Asia) Singapore $2.17M AUM 37.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Credit Suisse's IH Position: Q4 2021 in Review

Credit Suisse sold out of iHuman (IH) in Q4 2021, closing a stake of 11,597 shares — an estimated $54K sold.

Credit Suisse first reported a position in IH in Q4 2020 and held it in 4 quarters. The position peaked at $12.7M in Q4 2020. 8 funds tracked by Wall St. Rank hold IH as of Q4 2021.

Credit Suisse reported no remaining iHuman position as of Q4 2021 after selling out during the quarter.
Credit Suisse sold 11,597 iHuman shares in Q4 2021, an estimated $54K.
Credit Suisse first reported a position in iHuman in Q4 2020 and held it in 4 quarters.
Credit Suisse's iHuman position peaked at $12.7M in Q4 2020.
8 funds tracked by Wall St. Rank held iHuman as of Q4 2021.

Based on Credit Suisse's 13F filing for Q4 2021, filed 14 Feb 2022.